Directly, a NGFR transcriptomic signature is elevated in persister cells that survive ICI treatment and that among four mouse melanomas that mimic human transcriptomic profiles, de-differentiated cancers were resistant to anti-PD1 therapy23,67. This evidence concerns the gene NGFR and melanoma.